In their new white paper on the future of temperature monitoring, TSS outlines what benefits pharmaceutical companies will realize from a cloud information service solution completely independent of the logger device, appointing profound information management the key to long-term success.
Recognizing that all loggers, no matter what supplier, more or less record the same set of data implies that the value provided to pharmaceutical companies lies in the information rather than in the logger device. There is no doubt about it; the pharmaceutical industry is facing a fundamental change.
“I see with excitement how the industry is changing, demanding an increased focus on information rather than the logger device. A logger is just a logger, while being able to effectively capture, analyze, and present data brings infinite possibilities for temperature monitoring” / Niclas Ohlsson, CEO
In their paper, TSS moves beyond the traditional approach, announcing that focus must be shifted from the device to how data can be captured, analyzed, and presented most efficiently and intuitively, to better fulfill the needs of the pharmaceutical companies.
By reading this white paper, you will understand why the time for a change is now. You will also learn about the advantages that an information-oriented solution would imply for a company like yours, such as extensive integration capabilities, streamlined processes, low total cost of ownership, and responsiveness to emerging technologies.
“In today’s ever-changing environment, it is necessary to have an information-oriented solution that allows you to evolve with the market, so that you don’t risk become locked into a logger technology that sooner or later will get outdated, Ohlsson says and continues: “We are dedicated to provide you with such solution”.
Follow the link to download the white paper: http://ow.ly/KYbIT
For more information, visit www.tss.se